REG - Belluscura PLC - Result of Share Placing

BelluscuraAnnouncement

07/02/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250207:nRSG3272Wa&default-theme=true

RNS Number : 3272W  Belluscura PLC  07 February 2025

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO
THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF
SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION
OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN
OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR
OR OTHERWISE ACQUIRE ANY NEW SHARES OF BELLUSCURA PLC.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF ENGLISH LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"), AND IS
DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF
MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

7 February 2025

 

Belluscura plc

("Belluscura" or the "Company")

 

Result of Placing

 

Belluscura plc (AIM: BELL), a UK medical device company focused on developing
oxygen enrichment technology spanning broad industries and therapies, is
pleased to announce that, further to the Company's announcement on 6 February
2025, the Company has conditionally raised gross proceeds of approximately
£4.0 million (approximately $5.0 million) through the placing of 199,151,375
new ordinary shares of £0.01 each in the Company (the "Placing Shares") with
certain existing and new institutional and other investors at the Issue Price
of 2 pence per new Placing Share.

The Placing Shares, in aggregate, represent approximately 118.3 per cent. of
the issued share capital of the Company prior to the Placing.

Dowgate and Allenby acted as joint brokers in respect of the Placing.

The result of the WRAP Retail Offer, which will be launched shortly, is
expected to be announced separately on 10 February 2025.

Unless otherwise stated, capitalised terms not otherwise defined in the text
of this announcement have the same meanings ascribed to them as in the
"Proposed Share Placing" announcement published by the Company on 6 February
2025.

 

First Admission and Total Voting Rights

An application has been made to London Stock Exchange plc for the 33,000,000
Firm Placing Shares to be admitted to trading on AIM ("First Admission"). It
is expected that First Admission will become effective and dealings in the
First Placing Shares will commence at 8.00 a.m. on 11 February 2025. The issue
and allotment of the First Placing Shares is conditional upon, inter alia,
First Admission becoming effective and the placing agreement entered into
between the Company, Dowgate, Allenby and SPARK ("Placing Agreement") not
being terminated in accordance with its terms.

Following First Admission, the Company's enlarged issued ordinary share
capital will be 201,408,232 ordinary shares of £0.01 each in the Company.
This figure may be used by shareholders in the Company as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change in their interest in, the share capital of the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Second Admission

Admission of the 166,151,375 Conditional Placing Shares and the WRAP Retail
Offer Shares is conditional, inter alia, upon the passing of the Resolutions
by the Company's Shareholders at a General Meeting to be held on 28 February
2025, notice of which will be set out in the Circular. The Circular is
expected to be dispatched to Shareholders on 11 February 2025.

A further announcement will be made following the General Meeting, which will
include the total voting rights in the Company's share capital following
admission of the Conditional Placing Shares and WRAP Retail Offer Shares.

 

Director Participations

Adam Reynolds, Robert Rauker, David Poutney, Richard Piper, Dr. Patrick
Strollo and Paul Tuson, each of whom are Directors of the Company (the
"Participating Directors"), have agreed to participate in the Conditional
Placing for an aggregate of 8,822,344 Conditional Placing Shares at the Issue
Price. On Second Admission, following the issue of the Conditional Placing
Shares, the interests of the Participating Directors in the Company's enlarged
share capital will be as follows:

 Director       Number of Ordinary Shares held as at the date of this announcement  Number of Conditional Placing Shares subscribed for  Resulting number of Ordinary Shares held immediately following Second  Percentage Holding immediately following Second Admission*
                                                                                                                                         Admission

 Adam Reynolds  2,033,176                                                           2,512,057                                            4,545,233                                                              1.18%
 Robert Rauker  1,035,684                                                           2,009,646                                            3,045,330                                                              0.79%
 David Poutney  14,255,731                                                          1,004,823                                            15,260,554                                                             3.96%
 Ric Piper      80,000                                                              1,728,295                                            1,808,295                                                              0.47%
 Pat Strollo     -                                                                  964,630                                              964,630                                                                0.25%
 Paul Tuson      -                                                                  602,893                                              602,893                                                                0.16%

 

*assuming full subscription of the WRAP Retail Offer

 

This announcement should be read in its entirety. In particular, you should
read and understand the information provided in the "Important Notices"
section below.

For further information please contact:

 

 Belluscura plc                                              Tel: +44 (0)20 3128 8100
 Adam Reynolds, Chairman

 Robert Rauker, Chief Executive Officer

 Simon Neicheril, Chief Financial Officer

 SPARK Advisory Partners Limited                             Tel: +44 (0)20 3368 3550

 Nominated Adviser
 Neil Baldwin / Jade Bayat

 Dowgate Capital Limited                                     Tel: +44 (0)20 3903 7715

 Joint Broker
 James Serjeant / Colin Clime (Sales and Corporate Broking)

 Russell Cook / Daniel Ingram (Corporate Finance)

 Allenby Capital Limited                                     Tel: +44 (0)20 3328 5656

 Joint Broker
 Guy McDougall / Amrit Nahal (Sales and Corporate Broking)

 Jeremy Porter / Lauren Wright (Corporate Finance)

 MHP                                                         Tel: +44 (0)20 3128 8100

 Financial PR & Investor Relations                           email: Belluscura@mhpgroup.com (about:blank)
 Katie Hunt/Matthew Taylor

 

For further information, please visit https://ir.belluscura.com/

 

IMPORTANT NOTICES

 

Dowgate and Allenby are authorised and regulated in the United Kingdom by the
FCA and are acting exclusively as joint brokers for the Company and no one
else in connection with the Placing, the contents of this announcement or any
other matters described in this announcement. SPARK is acting as Nominated
Adviser to the Company for the purposes of the AIM Rules. Each of SPARK,
Dowgate and Allenby will not regard any other person as its client in relation
to the Placing, the content of this announcement or any other matters
described in this announcement and will not be responsible to anyone
(including any Placees) other than the Company for providing the protections
afforded to its clients or for providing advice to any other person in
relation to the Placing, the content of this announcement or any other matters
referred to in this announcement. SPARK's responsibilities as Nominated
Adviser to the Company are owed solely to the London Stock Exchange and are
not owed to the Company or to any Director or to any other person.

 

This announcement is being issued by and is the sole responsibility of the
Company. No representation or warranty, express or implied, is or will be made
as to, or in relation to, and no responsibility or liability is or will be
accepted by or on behalf of SPARK, Dowgate or Allenby (apart from the
responsibilities or liabilities that may be imposed by FSMA or the regulatory
regime established thereunder) and/or by any of its affiliates and/or any of
its representatives as to, or in relation to, the accuracy, adequacy, fairness
or completeness of this announcement or any other written or oral information
made available to or publicly available to any interested party or their
respective advisers or any other statement made or purported to be made by or
on behalf of SPARK, Dowgate, Allenby and/or any of their affiliates and/or by
any of their representatives in connection with the Company, the Placing
Shares or the Placing and any responsibility and liability whether arising in
tort, contract or otherwise therefor is expressly disclaimed. No
representation or warranty, express or implied, is made by SPARK, Dowgate,
Allenby and/or any of their affiliates and/or any of their representatives as
to the accuracy, fairness, verification, completeness or sufficiency of the
information or opinions contained in this announcement or any other written or
oral information made available to or publicly available to any interested
party or their respective advisers, and any liability therefor is expressly
disclaimed.

 

The Placing Shares have not been and will not be registered under the
Securities Act or under the applicable securities law or with any securities
regulatory authority of any state or other jurisdiction of the United States
or under the securities laws of Australia, Canada, Japan, New Zealand, the
Republic of South Africa or any state, province or territory thereof or any
other jurisdiction outside the United Kingdom and may not be offered, sold,
pledged, taken up, exercised, resold, renounced, transferred or delivered,
directly or indirectly, through CREST or otherwise, within, into or from
Canada, Australia, Japan, New Zealand, the Republic of South Africa or the
United States, or to, or for the account or benefit of, any person with a
registered address in, or who is a resident or ordinary resident in, or a
citizen of such jurisdictions or to any person in any country or territory
where to do so would or might contravene applicable securities laws or
regulations except pursuant to an applicable exemption. Any securities of the
Company will only be offered and sold outside of the United States in
"offshore transactions" within the meaning of and in reliance on the safe
harbour from the registration requirements under the Securities Act provided
by Regulation S promulgated thereunder.  The securities of the Company have
not been approved or disapproved by the US Securities and Exchange Commission,
any state securities commission or other regulatory authority in the United
States, nor have any of the foregoing authorities passed upon or endorsed the
merits of the Placing or the accuracy or adequacy of this presentation.  Any
representation to the contrary is a criminal offence in the United States.
Subject to certain exceptions, the securities referred to herein may not be
offered or sold in the United States, Australia, Canada, Japan, New Zealand,
the Republic of South Africa or to, or for the account or benefit of, any
national, resident or citizen of the United States, Australia, Canada, Japan,
New Zealand or the Republic of South Africa.

 

No public offering of securities is being made in the United States.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROIUPUAWPUPAUQM